Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Start-Up Speed vs. Total Trial Success: Balancing RTSM Priorities
Don't let a fast startup compromise years of clinical success. Learn how to balance initial build speed with the long-term flexibility needed to handle protocol amendments and complex integrations.
Where Study Simulation Fits In Clinical Trials
Simulation lets teams test assumptions early, showing how design and operations affect timelines, cost, and feasibility — reducing risk and enabling confident, data‑driven decisions.
Evidence Of An Industry's Readiness To Collaborate
The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.
Health Economics And Outcomes Research (HEOR) Explained
Learn about this accessible way to understand what HEOR is, how it’s used, and its impact on people and healthcare systems.

How To Accelerate Early-Phase Oncology Trial
5/12/2026

Purpose-built early-phase oncology sites can enroll patients within 7–10 days post-activation while maintaining quality and diversity; academic centers often lag due to complexity and saturation.
Cell And Gene Therapy Field Quiet In Q2
8/15/2024

While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.
Beyond The Database: Reaching Real Patients In Real Communities
5/14/2025

There’s fatigue around “database-only” recruitment tactics. This presentation spotlights how patient-centric, local engagement are outperforming traditional pipelines.
RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It Matters
2/25/2026

Explore why RTSM should be viewed as a system for managing change. Learn how platform-based reusability reduces UAT churn, preserves institutional memory, and stabilizes mid-study amendments.
DCT Solutions That Successfully Deliver Results
10/28/2025

Catch MRN COO, Todd McGrath, speaking on the impact DCT/hybrid trial design can have on overall trial success, noting that there is no "one-size-fits-all" — it takes a tailored approach to achieve maximum results.

Ten Big Questions To Ask Your Clinical Transparency Solution Partner

When considering clinical trial disclosure solutions, it is important to understand the potential partner’s practical experience and how their solution fits your compliance needs today and in the future.
Simulants: Unlock Insights And Accelerate Medical Breakthroughs

Get an overview of this groundbreaking synthetic data product – uniquely derived from Medidata’s exclusive repository of global, standardized historical clinical trial data.
Supporting Patients For Better Clinical Trials

From our inception, Ergomed has been committed to enhancing the patient journey in clinical trials. Our unique Ergomed CARE™ approach revolutionizes trials by optimizing the patient experience. Designed to address and resolve issues proactively, this comprehensive approach supports and engages all stakeholders, leading to accelerated study start-up, improved patient recruitment and retention, and investigator engagement.
User Acceptance Testing (UAT): Keeping Trials On Track

Validate endpoint performance and security before deployment with structured UAT that reduces risk, ensures compliance, and enhances user experience through real-world testing.
Post-Marketing Studies And Real-World Evidence Clinical Trials

Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.